Pharmafile Logo

Confidential contracting

- PMLiVE

Merck KGaA appoints chief strategy officer

Isabel De Paoli will take up the role from 1 October

China flag thumb

China: Smoking prevalence greater in men while women kick habit

New study also finds the number of cigarettes smoked daily has risen

- PMLiVE

Sandoz seeks mobile-enabled health access solutions

Launches global competition inviting submissions via Facebook

- PMLiVE

Transformational technology

Big data, the cloud and the value of insights

- PMLiVE

NICE backs Bayer’s Eylea as first-line BRVO treatment

Recommends visual impairment therapy over current laser treatment

- PMLiVE

Iris Pauporté joins OSE Immunotherapeutics

She becomes clinical project director at the French biotech

Shire Basingstoke

Shire gives up on Momenta-partnered Humira biosimilar

Will fund programme for another 12 months while divesting ongoing activities to Momenta

- PMLiVE

Amgen’s Kyprolis scarred by head-to-head duel with Velcade

Failed to show superior progression-free survival in first-line treatment trials

- PMLiVE

Is there an ROI on KOLs?

Can you measure return on investment (ROI) from compliant, patient-centred skills training for key opinion leaders?

- PMLiVE

Grünenthal research consortium receives €1.5m EU grant

Wins funding for development of efficacy testing in neuropathic pain treatments

- PMLiVE

Novartis’ Ilaris wins three new FDA approvals

Immunotherapeutic expands in rare Periodic Fever Syndrome conditions

- PMLiVE

IBD Oxford MasterClass 2016 harnesses the chemistry between science and clinical practice

Leading Edge, part of the Lucid Group, delivered another successful Oxford MasterClass this year, which attracted over 260 delegates and 60 international inflammatory bowel disease (IBD) faculty, representing Europe, Asia, Australasia...

Lucid Group Communications Limited

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links